Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Useful Links to Oncology Journals

Top Oncology Journals Ranked by Impact Factor

Note: The content of some journals is restricted to subscribers

  • Annals of Oncology
    The official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology (JSMO). Annals of Oncology is an international journal at the forefront of its field, publishing articles on innovative cancer treatments, translational research relating to oncology and precision medicine. The journal addresses medical oncology, surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
  • ESMO Open
    ESMO Open, an open access, journal of the European Society for Medical Oncology, is an online-only, peer-reviewed oncology journal dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research.
    Led by Editor-in-Chief John Haanen, IOTECH is a new, peer-reviewed, open access journal from ESMO.
    It covers novel Immuno-Oncology topics and developments, both clinically and preclinically, with a focus on adoptive cell therapy, cancer vaccine development and new macromolecules.​
  • ESMO Gastrointestinal Oncology
    Led by Editors-in-Chief Irit Ben-Aharon and Florian Lordick, ESMO Gastrointestinal Oncology is a new, peer-reviewed, open access journal from ESMO.
    It is the European Society for Medical Oncology's latest peer-reviewed open access journal, dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.
  • ESMO Real World Data and Digital Oncology
    Led by Editor-in-Chief Rodrigo Dienstmann, ESMO Real-World Data and Digital Oncology is a new, peer-reviewed, open access journal from ESMO.
    It is the European Society for Medical Oncology's latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand.
  • ESMO affiliated journals
    ESMO is affiliated with selected journals which support its mission and benefit ESMO members: Cancer Treatment Reviews; Clinical Lymphoma Myeloma and Leukemia;
    Lung Cancer; The Breast
  • CA: A Cancer Journal for Clinicians
    CA provides cancer care professionals with up-to-date information on all aspects of cancer diagnosis, treatment, and prevention. The journal focuses on keeping physicians and healthcare professionals informed by providing scientific and educational information in the form of comprehensive review articles and online continuing education activities on important cancer topics and issues that are important to cancer care, along with publishing the latest cancer guidelines and statistical articles from the American Cancer Society.
  • The Lancet Oncology
    The Lancet Oncology publishes reviews on any topic connected with oncology, focusing on original research that advocates change in, or illuminates, oncological clinical practice. The journal publishes a range of article types that encompass all aspects of oncological medicine: Comment, Correspondence, News, Cancer and Society, Article, Review, Historical Review, Health-care Development, and Personal View.
  • Cancer Cell
    Cancer Cell covers topics including, but not limited to, molecular and cellular mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, development of cancer therapies and translational research. In addition, the journal publishes the results of selected clinical investigations. Access is provided free 12 months after publication.
  • Journal of Clinical Oncology
    JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, haematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, paediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology.
  • Cancer Discovery
    Cancer Discovery publishes articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.
  • Journal of the National Cancer Institute
    The Journal of the National Cancer Institute publishes peer-reviewed original research and is a source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment.
  • Leukemia
    Leukemia covers all aspects of the research and treatment of leukaemia and allied diseases. Studies of normal haemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukaemia genomics, cell cycle, signal transduction, and molecular targets for therapy.
  • Cancer Research
    Cancer Research publishes articles spanning the spectrum of cancer research with a focus on molecular and cellular pathobiology, stem cell biology, microenvironment, and integrated systems and technology.
  • Seminars in Cancer Biology
    Seminars in Cancer Biology is a review journal of developments in the field of molecular oncology on a topic by topic basis. Each issue is devoted to a single important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area.
  • Oncogene
    Oncogene covers all aspects of the structure and function of oncogenes, especially: cellular oncogenes and their mechanism of activation, structure and function of their encoded proteins, oncogenes of the DNA and RNA tumour viruses, the molecular oncology of human tumours, tumour suppressor genes, growth regulatory genes, cell cycle control, growth factors and receptors, apoptosis, and immortalisation and cellular senescence.
  • Clinical Cancer Research
    Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalised medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics.
  • BBA - Reviews on Cancer
    BBA - Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasising oncogenes and tumour suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development, rational anti-tumour drug design.
  • The Journal of Pathology
    The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease.
  • Stem Cells
    STEM CELLS publishes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects from the bench to patient care. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.
  • Oncotarget
    Oncotarget publishes research papers of general interest in all areas of biology and medicine: in translational, basic and clinical research including but not limited to oncogenes, oncoproteins and tumour suppressors, signalling pathways as potential targets for therapeutic intervention, shared targets in different diseases (cancer, benign tumours, atherosclerosis, eukaryotic infections, metabolic syndrome and other age-related diseases), chemotherapy and new therapeutic strategies.
  • Cancer Treatment Reviews
    Cancer Treatment Reviews keeps both the clinician and researcher abreast of developments in cancer treatment research through the evidence-based reviews. Each issue provides topical reviews under the following regular sections: comments on controversy, tumour reviews, anti-tumour treatments, new drugs, complications of treatment, general and supportive care and laboratory/clinic interface.
  • Cancer and Metastasis Reviews
    The transformation of biology from a descriptive, phenomenological discipline to one in which the regulatory principles are understood and predictably manipulated brings new opportunities to the study of cancer and the search for effective therapeutic modalities. Cancer and Metastasis Reviews offers a forum for critical review and discussion of these challenges.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.